Literature DB >> 24979533

Nanospray technology for an in situ gelling nanoparticulate powder as a wound dressing.

Felicetta De Cicco1, Amalia Porta1, Francesca Sansone1, Rita P Aquino1, Pasquale Del Gaudio2.   

Abstract

In the current study the feasibility of the novel nano spray drying technique for the production of stable nanoparticulate dry powder, able to gel when administered locally on a wound, is explored. Gentamicin sulphate (GS) was loaded into alginate/pectin nanoparticles as highly soluble (hygroscopic) model drug with wide range antibacterial agent for wound dressing. The influence of process variables, mainly spray mesh size and feed concentration, on particle size and morphology, powder wound fluid uptake ability and gelling rate, as well as hydrogel water vapour transmission at wound site were studied. Particles morphology was spherical with few exceptions as slightly corrugated particles when the larger nozzle was used. Production of spherical nanoparticles (d50 ∼ 350 nm) in good yield (82-92%) required 4 μm spray mesh whereas 7 μm mesh produced larger wrinkled particles. Nano spray-dried particles showed high encapsulation efficiency (∼ 80%), good flowability, high fluid uptake, fast gel formation (15 min) and proper adhesiveness to fill the wound site and to remove easily the formulation after use. Moreover, moisture transmission of the in situ formed hydrogel was between 95 and 90 g/m(2)/h, an optimum range to avoid wound dehydration or occlusion phenomena. Release of the encapsulated GS, monitored as permeation rate using Franz cells in simulated wound fluid (SWF) was related to particle size and gelling rate. Sustained permeation profiles were obtained achieving total permeation of the drug between 3 and 6 days. However, all nano spray-dried formulations presented a burst effect, suitable to prevent infection spreading at the beginning of the therapy. Antimicrobial tests against Staphylococcus aureus and Pseudomonas aeruginosa showed stronger and prolonged antimicrobial effect of the nanoparticles compared to pure GS both shortly after administration and over time (till 12 days).
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial activity; In situ gelling dry powder; Nanoparticles by spray-drying; Topical antibiotic controlled release; Wound dressing

Mesh:

Substances:

Year:  2014        PMID: 24979533     DOI: 10.1016/j.ijpharm.2014.06.049

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Comparative Evaluation of Antimicrobial, Antiamoebic, and Antiviral Efficacy of Ophthalmic Formulations.

Authors:  Ciro Caruso; Daniela Eletto; Alessandra Tosco; Martina Pannetta; Fabio Scarinci; Mario Troisi; Amalia Porta
Journal:  Microorganisms       Date:  2022-06-04

Review 2.  Applications of Alginate-Based Nanomaterials in Enhancing the Therapeutic Effects of Bee Products.

Authors:  Mohammad A I Al-Hatamleh; Walhan Alshaer; Ma'mon M Hatmal; Lidawani Lambuk; Naveed Ahmed; Mohd Zulkifli Mustafa; Siew Chun Low; Juhana Jaafar; Khalid Ferji; Jean-Luc Six; Vuk Uskoković; Rohimah Mohamud
Journal:  Front Mol Biosci       Date:  2022-04-11

3.  Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders.

Authors:  Rita Patrizia Aquino; Mariateresa Stigliani; Pasquale Del Gaudio; Teresa Mencherini; Francesca Sansone; Paola Russo
Journal:  ScientificWorldJournal       Date:  2014-12-16

4.  Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract.

Authors:  Rita P Aquino; Giulia Auriemma; Giulio M Conte; Tiziana Esposito; Eduardo Sommella; Pietro Campiglia; Francesca Sansone
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

5.  In Situ Hydrogel-Forming/Nitric Oxide-Releasing Wound Dressing for Enhanced Antibacterial Activity and Healing in Mice with Infected Wounds.

Authors:  Juho Lee; Shwe Phyu Hlaing; Jiafu Cao; Nurhasni Hasan; Hye-Jin Ahn; Ki-Won Song; Jin-Wook Yoo
Journal:  Pharmaceutics       Date:  2019-09-27       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.